Core Viewpoint - Company expects a net loss of 450 million to 640 million yuan for the year 2025, with a projected net profit excluding non-recurring losses ranging from -770 million to -540 million yuan [1] Group 1: Financial Performance - The company's bioenergy segment revenue increased by approximately 580 million yuan, representing a year-on-year growth of about 46% due to rising product prices and capacity release [1] - The gross profit for the bioenergy segment increased by approximately 270 million yuan, leading to a turnaround from loss to profit, significantly enhancing operational efficiency [1] - The company anticipates asset impairment losses of around 250 million yuan for the reporting period, based on cautious principles and evaluations of inventory and fixed assets [1] Group 2: Market Environment - The global green energy policy environment continues to improve, with the EU and UK implementing regular biojet fuel (SAF) blending policies, and major economies like China, Japan, and South Korea clarifying their green transition paths [1] - The company successfully obtained approval for SAF product export in October 2025, marking a strategic breakthrough in its development [1] Group 3: Challenges in Other Segments - The company's environmental materials and chemical products business faced challenges due to cyclical adjustments in the petroleum refining and coal chemical industries, leading to a pressured market environment for catalyst and purification products [1] - The rapid expansion of capacity in the LNG and neopentyl glycol industries outpaced demand growth, exacerbating competition within the industry [1]

海新能科公告，预计2025年度归属于上市公司股东的净利润为-6.4亿元至-4.5亿元，同比减亏。报告期 内，公司环保材料及化工产品业务面临挑战。受石油炼化及煤化工产业周期性调整影响，国内催化剂净 化剂业务市场环境承压；同时，煤气清洁利用（LNG）及新戊二醇行业阶段性产能扩张快于需求增 长，供需失衡加剧行业竞争。在上述因素综合影响下，该业务板块营业收入及净利润同比出现下滑。 ...

Financial Performance - The company achieved a revenue of 958 million CNY in Q3 2025, representing a year-on-year growth of 63.82% [2] - The net profit attributable to shareholders for Q3 2025 was 93.33 million CNY, with a total revenue of 1.942 billion CNY and a net profit of 57.95 million CNY for the first three quarters, marking a turnaround from losses [2][3] - Total liabilities significantly decreased, with a debt ratio of 29.81% as of September 2025, down from 38.99% at the end of 2024, a reduction of 9.18% [2] Operational Improvements - The company capitalized on the rising market for hydrocarbon-based biodiesel, leading to profitability primarily from the bioenergy sector [3] - Innovations in sales strategies and successful execution of long-term contracts with non-EU clients contributed to performance improvements [3] - Key operational metrics improved due to technological innovations and equipment upgrades, resulting in lower processing costs and enhanced risk resilience [3] Accounts Receivable Management - As of September 2025, accounts receivable stood at 503 million CNY, a decrease of 27 million CNY from the previous year [3] - Other receivables dropped to 181 million CNY, down 1.168 billion CNY from the previous year-end [3] - The company implemented measures such as enhanced credit tracking and legal actions to improve collection efficiency, optimizing its asset-liability structure [3] Market Trends and Future Outlook - The average offshore price of ARA SAF reached 2,854 USD/ton as of October 31, driven by regulatory policies and rising demand [4][5] - The company anticipates sustained high demand for SAF due to strengthened enforcement of blending mandates across various regions [5] - The company plans to actively explore domestic and international markets for biofuels, aiming for full production and sales of bioenergy products [5] Strategic Development Plans - Over the next three years, the company aims to focus on green development and technological innovation, aspiring to become a leading global green energy supplier [6] - The bioenergy sector will be the core strategic pillar, with a commitment to long-term investment and efficiency improvements [6] - Plans include enhancing the competitiveness of catalytic purification products and increasing R&D efforts in bioenergy and catalytic purification technologies [6]

Financial Performance - The company's net profit attributable to shareholders decreased by 89.15% year-on-year in the first half of 2025, attributed to internal management improvements and external market opportunities [2] - Significant reductions in processing costs and improved production indicators were achieved through technological innovation and equipment upgrades [2][3] - The average price of Argus FOB ARA low-congealing bio-diesel increased by 13.06% year-on-year, indicating a positive trend in bioenergy product pricing [3] Market Dynamics - SAF prices have been rising, with Argus FOB ARA prices reaching approximately $2,600 per ton due to enforced blending policies and rising raw material costs [4] - The EU has introduced subsidy plans to accelerate SAF adoption, which is expected to enhance demand and further drive price increases [4] Research and Development - The company aims to enhance production efficiency through practical innovation, focusing on raw material pre-treatment, catalyst development, and product diversification [5] - Collaboration with external universities and research institutions is emphasized to foster joint research and technology introduction [5] Future Development Strategy - The company plans to become a world-class green energy supplier and a leader in bioenergy technology innovation over the next three years [6] - Key strategic initiatives include enhancing bioenergy growth, improving catalyst purification product competitiveness, and maintaining high R&D investment levels [6] Bioenergy Sector Focus - The company is concentrating on the development and market promotion of biodiesel and bio-jet fuel, with a focus on process optimization and key customer development [6] - Efforts are being made to implement second-generation bioenergy applications domestically, contributing to national energy security and emissions reduction [6]